Atopix Competitors and Similar CompaniesClear all
Atopix's competitors and similar companies include AKESOgen, Biothera, Akebia Therapeutics and Aceragen.
 Atopix Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK |  AKESOgen AKESOgen is a biomarker, genomics and pharmacogenomics contract research organization that services the academic, pharmaceutical, biotechnology and agricultural |  Biothera Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems. |  Aceragen Aceragen (formerly known as Idera Pharmaceuticals) is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates. | ||
Founding Date | Founding Date 2012 | Founding Date 2010 | Founding Date 1997 | Founding Date 2007 | Founding Date 1989 |
Type | Type Private | Type Subsidiary | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Milton, GB HQ | Locations Norcross, US HQ | Locations Roseville, US HQ | Locations Cambridge, US HQ | Locations Durham, US HQ |
Employees | Employees N/A | Employees 6 | Employees 542% increase | Employees 324187% increase | Employees 3642% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 359.6 m | Valuation ($) 3.2 m |
Financial | |||||
Revenue (est.) | Revenue (est.) £453.4k (FY, 2017) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $236.2m (FY, 2025) | Revenue (est.) $4.9m (FY, 2022) |
Net income | Net income £592.1k (FY, 2017) | Net income N/A | Net income N/A | Net income ($5.3m) (FY, 2025) | Net income ($23.4m) (FY, 2022) |
Funding | |||||
Latest funding round | Latest funding round $ 5.1m (almost 11 years ago) | Latest funding round N/A | Latest funding round $ 1.6m (over 11 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 5.1m | Total funding raised $ 1.5m | Total funding raised $ 5.1m | Total funding raised N/A | Total funding raised $ 13.8m |
For sources of this data, please see the company profile
View Company Profiles
AKESOgen
HQ
Norcross, US
AKESOgen is a biomarker, genomics and pharmacogenomics contract research organization that services the academic, pharmaceutical, biotechnology and agricultural
View companyBiothera
HQ
Roseville, US
Employees
54↑ 2% increase
Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems.
View company
Akebia Therapeutics
HQ
Cambridge, US
Employees
324
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
View companyAceragen
HQ
Durham, US
Employees
36↓ 42% decrease
Aceragen (formerly known as Idera Pharmaceuticals) is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
View company